The kidney peptides in Renolux are derived from the Khavinson bioregulator known as Pielotax (also referred to as A-9 or kidney peptide complex). These are short-chain, low-molecular-weight peptides (typically up to 5,000–10,000 Daltons, often di-, tri-, or tetrapeptides like AED, EDL, or AEDG sequences in related studies) extracted from the kidney tissue of young, healthy animals (usually calves under 12 months old). In Vita Detox, each capsule provides about 15 mg of these kidney-specific peptides as part of the 75 mg total active blend.

​

Mechanism of Action

​

Like other Khavinson bioregulators, these peptides exhibit tissue-specific tropism—they preferentially target kidney cells (e.g., nephrons, tubular cells) to:

• Interact with DNA (often in promoter or regulatory regions), modulating gene expression.

• Normalize protein synthesis in renal tissue.

• Promote cellular repair, regeneration, and metabolic restoration in damaged or age-stressed kidneys.

• Reduce oxidative stress and regulate peroxidation processes.

• Enhance overall cellular homeostasis and reserve capacity of the urinary system.

 

They work by addressing peptide deficiencies that accumulate with age, toxin exposure, or chronic stress, helping restore the kidney's "optimal functional memory" at an epigenetic-like level. These peptides are orally bioavailable, cross barriers, and act intracellularly without needing to be injected.

​

Key Claimed Benefits (From Studies and Clinical Observations)

​

Research, primarily from the St. Petersburg Institute of Bioregulation and Gerontology (under Prof. Khavinson) and related animal/human trials, along with user reports, includes:

​

• Improved kidney filtration and function: Increases diuresis (urine output) by 1.2–1.4 times in aging models; enhances glomerular filtration and tubular reabsorption (e.g., distal sodium transport up by 1.2–1.3 times in some peptide variants).

• Reduced protein loss and proteinuria: Lowers urine protein levels and excretion (e.g., by 1.5–3.1 times in rat studies on aging kidneys), supporting glomerular barrier integrity.

• Nephroprotective effects: Protects against age-related decline, toxin-induced damage, or overload; may help in conditions like chronic kidney issues, gout nephropathy (reducing uric acid/urea), urolithiasis (kidney stones), or post-stress recovery.

• Antioxidant and anti-inflammatory support: Regulates peroxidation, boosts adaptation to extreme conditions, and improves energy supply/metabolism in kidney tissue.

• Metabolic and detox enhancement: Aids in waste removal, electrolyte balance, fluid regulation, and blood pressure stabilization via better renal handling of toxins, metabolites, and excess substances.

• General vitality: Users often report better energy, reduced fatigue from toxin buildup, and improved resilience during detox or recovery protocols.

 

In animal studies (e.g., old rats), peptides like PKC (polypeptide kidney complex), AED, EDL, and AEDG showed nephroprotective actions, including reduced protein excretion, better sodium handling, and overall morphofunctional improvement in aging kidneys. Clinical reports on Pielotax note activation of renal metabolism, improved secretory function, and biochemical marker shifts (e.g., better blood parameters in patients with kidney disorders).

​

Relevance to Gut Balancing and Autism Support

​

In autism spectrum contexts, where GI issues (dysbiosis, leaky gut) often lead to increased systemic toxin load (e.g., from gut-derived metabolites, LPS, or poor clearance), strong kidney function is crucial for efficient elimination. The kidneys filter blood continuously, removing waste that the liver processes and excretes (via bile/urine). Impaired detox can exacerbate neuroinflammation or behavioral symptoms via the gut-brain-kidney axis.

​

Kidney peptides in Vita Detox may provide foundational support by:

​

• Enhancing clearance of gut-sourced toxins/metabolites during microbiome rebalancing (e.g., when using antimicrobials, binders, or probiotics, which can increase die-off load).

• Reducing oxidative stress and supporting filtration to prevent toxin recirculation or buildup.

• Complementing liver/bile components for full detox pathway optimization, potentially easing the body's burden while addressing gut permeability or inflammation.

 

Direct studies on Pielotax/kidney peptides for autism are not available (Khavinson research focuses more on aging, organ repair, and general physiology), but the detox and metabolic benefits align with biomedical ASD approaches emphasizing toxin reduction, oxidative stress mitigation, and organ support.

 

These are supplements (not pharmaceuticals in most Western regulations), with evidence mainly from Russian-origin studies, animal models, and anecdotal/clinical observations rather than large-scale RCTs. Individual results vary. They're generally considered safe with no major side effects reported, but consult a healthcare provider familiar with functional/biomedical ASD protocols for use.